Bowel cancer research
Bowel cancer is the third most common cancer in the UK. More than 36,500 people are diagnosed with this disease and around 16,000 people die of bowel cancer each year in the UK.
The good news is that survival rates have doubled over the last 30 years and over half of people diagnosed with bowel cancer will survive for at least five years after diagnosis. But we still have a long way to go.
Cancer Research UK is a major supporter of research into all aspects of bowel cancer. In 1993, Stephanie Moore M.B.E. established the The Bobby Moore Fund in partnership with Cancer Research UK, to raise money for research into this disease.
We also provide a range of information materials aimed at patients and carers - there is a section dealing extensively with bowel cancer on our CancerHelp website.
Below are some of the highlights of our bowel cancer research portfolio.
Or find out more on our bowel cancer briefsheet (PDF download, 591kb)
On this page
Cancer biology
Prof Inke Näthke
Cell and Developmental Biology
University of Dundee, Dundee
The role of APC in bowel cancer
Prof Trevor Dale
School of Biosciences
Cardiff University, Cardiff
Studying gene faults involved in liver and bowel cancer
Dr Owen Sansom
Wnt Signalling and Colorectal Cancer Group
Beatson Institute for Cancer Research, Glasgow
Understanding the molecular mistakes in bowel cancer
Dr Doug Winton
Stem Cell Biology of the Intestine Group
Cambridge Research Institute, Cambridge
Studying stem cells in bowel cancer
Cancer genes
Prof Malcolm Dunlop
Department of Surgery, MRC Human Genetics Unit
Western General Hospital, Edinburgh
The genetic causes of bowel cancer
Prof Richard Houlston
Molecular and Population Genetics Team
The Institute of Cancer Research, Sutton
Genes and cancer
Prof Ian Tomlinson
Population and Functional Genetics Laboratory
Wellcome Trust Centre for Human Genetics, Oxford
Genes and bowel cancer
Chemotherapy
Prof Matt Seymour
School of Medicine
University of Leeds, Leeds
Testing new treatments for bowel cancer
Clinical trials
Prof Caroline Dive
Clinical and Experimental Pharmacology Group
Paterson Institute for Cancer Research, Manchester
Developing new cancer treatments
Prof John Primrose
Faculty of Medicine, Health and Life Sciences
University of Southampton, Southampton
Better treatments for bile duct cancer
Prof Matt Seymour
School of Medicine
University of Leeds, Leeds
Testing new treatments for bowel cancer
Diet
Prof Chris Paraskeva
Colorectal Tumour Biology Research Group
University of Bristol, Bristol
Preventing and treating bowel cancer
Drug discovery & development
Prof Chris Paraskeva
Colorectal Tumour Biology Research Group
University of Bristol, Bristol
Preventing and treating bowel cancer
Drug resistance
Prof Caroline Dive
Clinical and Experimental Pharmacology Group
Paterson Institute for Cancer Research, Manchester
Developing new cancer treatments
Genes
Prof Alan Clarke
The Genetics Group, School of Biosciences
Cardiff University, Cardiff
Understanding how bowel cancer develops
Inequality
Dr Neil Campbell
Department of General Practice and Primary Care
University of Aberdeen, Aberdeen
Reducing inequalities in bowel cancer
Preventing cancer
Prof Malcolm Dunlop
Department of Surgery, MRC Human Genetics Unit
Western General Hospital, Edinburgh
The genetic causes of bowel cancer
Prof Chris Paraskeva
Colorectal Tumour Biology Research Group
University of Bristol, Bristol
Preventing and treating bowel cancer
Screening
Prof Wendy Atkin
Cancer Research UK Colorectal Cancer Unit
St Mary's Hospital, London
Detecting and preventing bowel cancer
Prof Jack Cuzick
Cancer Research UK Centre for Epidemiology, Mathematics and Statistics
Wolfson Institute, Barts and The London, Queen Mary's School of Medicine and Dentistry, London
Cancer prevention and screening
Prof Peter Sasieni
Biostatistics and Cancer Epidemiology Group
Wolfson Institute, Barts and The London, Queen Mary's School of Medicine and Dentistry, London
Improving cancer screening
Stem cells
Dr Owen Sansom
Wnt Signalling and Colorectal Cancer Group
Beatson Institute for Cancer Research, Glasgow
Understanding the molecular mistakes in bowel cancer
Dr Doug Winton
Stem Cell Biology of the Intestine Group
Cambridge Research Institute, Cambridge
Increase text
Decrease text
Print this page
